Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers

Active, not recruiting

Interventions: Other: Quality-of-Life Assessment
Other: Questionnaire Administration

Brief Summary: This trial studies the risk of developing disorders associated with chronic opioid use post-surgery in patients with head and neck cancers. Clinical data collection may help doctors to learn how often and how likely disorders associated with the use of opioid pain medication may occur in patients with head and neck cancer who are having surgery as part of their treatment plan.

Detailed Description: PRIMARY OBJECTIVES:

I. Assess prevalence of chronic opioid use and severity of symptom burden (M. D. Anderson Symptom Inventory-Head and Neck \[MDASI-HN\]) in patients undergoing surgery of head/neck cancer.

SECONDARY OBJECTIVES:

I. To investigate the extent of association of chronic opioid use with risk of opioid use disorder (as assessed by Screener and Opioid Assessment for Patients with Pain\[SOAPP-14\] and Cut down, Annoyed, Guilty and Eye Opener \[CAGE\] scores) and psychosocial factors (as assessed by MDASI).

II. To assess frequency of positive risk of opioid use disorder as assessed by Screener and Opioid Assessment for Patients tool (SOAPP-14) and CAGE-adapted to include drugs (AID).

III. Assess frequency of aberrant opioid use behaviors. IV. Assess frequency of post-operative complications.

OUTLINE:

Patients complete questionnaires and quality of life assessments over 10-15 minutes at pre-surgery, after-surgery, at discharge, within 2-3 weeks after surgery, and within 90 days after surgery.

Recruitment & Eligibility

Inclusion Criteria

Patients with head and neck cancer scheduled for combined head and neck surgery - plastic surgery free flap
Competent to give informed consent
Ability to read and write in English

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
Observational (questionnaires, quality of life assessment)	Questionnaire Administration	Patients complete questionnaires and quality of life assessments over 10-15 minutes at pre-surgery, after-surgery, at discharge, within 2-3 weeks after surgery, and within 90 days after surgery.
Observational (questionnaires, quality of life assessment)	Quality-of-Life Assessment	Patients complete questionnaires and quality of life assessments over 10-15 minutes at pre-surgery, after-surgery, at discharge, within 2-3 weeks after surgery, and within 90 days after surgery.

Primary Outcome Measures

Name	Time	Method
Association of chronic opioid use	At 90 days after surgery	Association of chronic opioid use with that of the CAGE-AID scores
Rate of chronic opioid use	At 90 days after surgery	Rate of chronic opioid use will be measured by the association of chronic opioid use with that of the risk of opioid misuse Screener and Opioid Assessment for Patients tool (SOAPP-14)
Severity of symptom burden	At 90 days after surgery	Will be measured by MDASI.

Secondary Outcome Measures

Name	Time	Method
Risk of opioid use will be assessed by CAGE-AID	Up to 90 days post surgery	CAGE-AID: Score of greater than or equal 2 is considered as risk factor for opioid misuse
Risk of opioid use assessed	Up to 90 days after surgery	Screener and Opioid Assessment for Patients with Pain\[SOAPP-14\] Score of greater than or equal 7 is considered as risk factor for opioid misuse.
Frequency of positive risk of opioid use disorder	Up to 90 days post surgery	Will be assessed by CAGE-adapted to include drugs (AID).
Frequency of aberrant opioid use behaviors	Up to 90 days post surgery	Correlation between categorical variables will be evaluated using Chisquare test or Fisher's exact test.
Frequency of post-operative complications	Up to 90 days post surgery	Correlation between categorical variables will be evaluated using Chisquare test or Fisher's exact test